186 related articles for article (PubMed ID: 33273168)
1. Adult Gliomas.
Colman H
Continuum (Minneap Minn); 2020 Dec; 26(6):1452-1475. PubMed ID: 33273168
[TBL] [Abstract][Full Text] [Related]
2. Adult-type Diffuse Gliomas.
de la Fuente MI
Continuum (Minneap Minn); 2023 Dec; 29(6):1662-1679. PubMed ID: 38085893
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies.
Muzyka L; Goff NK; Choudhary N; Koltz MT
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445633
[TBL] [Abstract][Full Text] [Related]
4. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A
Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
[TBL] [Abstract][Full Text] [Related]
5. Characterization of gliomas: from morphology to molecules.
Ferris SP; Hofmann JW; Solomon DA; Perry A
Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
[TBL] [Abstract][Full Text] [Related]
6. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
[TBL] [Abstract][Full Text] [Related]
7. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
8. Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas.
Ferguson SD; Zhou S; Huse JT; de Groot JF; Xiu J; Subramaniam DS; Mehta S; Gatalica Z; Swensen J; Sanai N; Spetzler D; Heimberger AB
J Neuropathol Exp Neurol; 2018 Jun; 77(6):437-442. PubMed ID: 29718398
[TBL] [Abstract][Full Text] [Related]
9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
10. Artificial Intelligence-Assisted Classification of Gliomas Using Whole Slide Images.
Jose L; Liu S; Russo C; Cong C; Song Y; Rodriguez M; Di Ieva A
Arch Pathol Lab Med; 2023 Aug; 147(8):916-924. PubMed ID: 36445697
[TBL] [Abstract][Full Text] [Related]
11. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
12. Karyotypes in 90 human gliomas.
Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R
Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072
[TBL] [Abstract][Full Text] [Related]
13. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis to complement histopathological diagnosis of brain tumors.
Nakamura M; Shimada K; Ishida E; Nakase H; Konishi N
Histol Histopathol; 2007 Mar; 22(3):327-35. PubMed ID: 17163407
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic Myelopathies.
Wu J; Ranjan S
Continuum (Minneap Minn); 2018 Apr; 24(2, Spinal Cord Disorders):474-496. PubMed ID: 29613896
[TBL] [Abstract][Full Text] [Related]
16. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
17. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
Daumas-Duport C; Koziak M; Miquel C; Nataf F; Jouvet A; Varlet P
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):247-53. PubMed ID: 16292168
[TBL] [Abstract][Full Text] [Related]
18. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
Latysheva A; Emblem KE; Brandal P; Vik-Mo EO; Pahnke J; Røysland K; Hald JK; Server A
Neuroradiology; 2019 May; 61(5):545-555. PubMed ID: 30712139
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological diagnosis of gliomas by genotype analysis].
Nakamura M; Shimada K; Nakase H; Konishi N
Brain Nerve; 2009 Jul; 61(7):773-80. PubMed ID: 19618854
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in
Batchala PP; Muttikkal TJE; Donahue JH; Patrie JT; Schiff D; Fadul CE; Mrachek EK; Lopes MB; Jain R; Patel SH
AJNR Am J Neuroradiol; 2019 Mar; 40(3):426-432. PubMed ID: 30705071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
